Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON51570Recruiting
Randomised, double-blind trial in anterior cruciate ligament injury comparing Adductor channel block with levobupivacaine with Adductor channel placebo block with sodium chloride (2 arms). Primary endpoint: Postoperative pain within 24 hours. Started Aug 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON51570.